Why was the Incannex share price put on ice today?

A capital raising is looming.

| More on:
Man with his hand out the front, symbolising a trading halt.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Incannex requested a trading halt today 
  • The medicinal cannabis products company intends to conduct a capital raising for institutional investors 
  • Incannex will resume trading as soon as a statement is made, or at the commencement of trading on Monday -- whichever comes first 

The Incannex Healthcare Ltd (ASX: IHL) share price went nowhere on Thursday after the company requested a trading halt before the market open.

The Incannex share price was 23 cents at the close yesterday.

Let's find out what's happening with this ASX cannabis share.

Why is the Incannex share price at a standstill?

According to a statement, Incannex intends to conduct a "strategic institutional capital raising".

Incannex asked the ASX to halt its share trading ahead of an official announcement explaining the detail of the raising.

Incannex shares will remain on ice until the commencement of normal trading on 5 December or upon the release of its announcement.

What's been happening at Incannex?

Incannex develops medicinal cannabinoid pharmaceutical products.

As my Fool colleague Brooke recently noted, Incannex shares had a shocker in October.

The company entered the S&P/ASX 300 Index (ASX: XKO) in September. The following month, the Incannex share price underperformed the index by 15%. And that was despite a series of seemingly positive market updates.

In November, Incannex shares dropped another 11.5%. Ouch.

Cannabis shares are a highly volatile category of the market. One of their biggest hurdles is regulatory restrictions.

Medicinal cannabis is simply not legal in many parts of the world — including numerous states in the enormous nascent United States market.

As my Fool colleague Bernd reports, US President Joe Biden wants marijuana use legalised.

In October, he announced he would pardon everyone convicted of simple possession.

ASX cannabis shares responded to that, with Incannex shares rising 11% over two days.

Incannex performance snapshot

Incannex shares are down 65% in the year to date.

Over the past five years, they are up 1,050%.

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

Broker says this ASX 200 biotech stock is a top buy

Let's see what Bell Potter is saying about this biotech.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Why CSL shares are a buy today despite the looming Trump tariffs

A leading expert believes CSL shares are still trading for a bargain today. Here's why.

Read more »

A businesswoman pulls her glasses down in shock to look at the bad news on her computer.
Healthcare Shares

Why did the Telix share price just crash 16%?

Investors are sending the Telix share price plunging today. But why?

Read more »

Broker analysing the share price.
Healthcare Shares

Expert: 2 ASX healthcare stocks to avoid before reporting season

Not all healthcare stocks are created equal.

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Should I buy Pro Medicus or CSL shares ahead of earnings season?

The ASX healthcare sector may be currently undervalued.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Healthcare Shares

Why Mesoblast shares can keep storming higher

More big returns could be on the way for buyers of this high risk stock according to Bell Potter.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

The Mesoblast share price just rocketed 38%! Here's why

ASX investors just sent the Mesoblast share price up 38%. But why?

Read more »

couple having a happy discussion with a banker
Healthcare Shares

Expert: 4 ASX healthcare stocks to buy ahead of reporting season

Could these ASX healthcare stocks be good additions to your portfolio?

Read more »